ArticleRheumatology advances in practice2026
Feasibility study of a smartphone app to monitor systemic sclerosis-related digital ulcers-a potential new tool for remote clinical monitoring.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the feasibility, in a clinical setting, of using a smartphone app that allows 'tracking' of SSc-related digital ulcers/lesions over time and to gauge patient opinion of the app's benefits, including a newly added lesion feedback function for patients. Methods: Patients with SSc with active digital ulcers/lesions were recruited and assessed twice: on study entry and at the point of lesion healing. Participants photographed their lesions and recorded patient-reported outcome measures (PROMs) with the app twice weekly. The lesion feedback function showed lesion size (measured from the photographs) over time. Ways in which feasibility was assessed included the number of photographs and PROMS recorded via the app, data from patient questionnaires and verbal feedback. Results: A total of 10 patients were recruited: 9 (90%) female, median age 55 years, median disease duration 12 years. Nine (90%) completed the study. The median duration of study participation per 'lesion episode' was 39 days (range 18-140). A total of 210 images were returned, with a median of 12 (range 4-87) per episode, and 99 sets of visual analogue scale/pain scores were returned, with a median of 7 (range 3-24) per episode. On a scale of 1 (very easy/helpful) to 10 (very difficult/not helpful), the median score for ease of sending photographs was 1 (range 1-3) and for helpfulness of feedback it was 1.5 (range 1-8). All patients were keen to use the app again. Conclusion: The feasibility and benefits of using the smartphone app, including the feedback function, lend support to possible wider use of the app in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.